thioctic acid has been researched along with Geographic Atrophy in 1 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
Geographic Atrophy: A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, BJ | 1 |
| Hunter, A | 1 |
| Brucker, AJ | 1 |
| Hahn, P | 1 |
| Gehrs, K | 1 |
| Patel, A | 1 |
| Edwards, AO | 1 |
| Li, Y | 1 |
| Khurana, RN | 1 |
| Nissim, I | 1 |
| Daniel, E | 1 |
| Grunwald, J | 1 |
| Ying, GS | 1 |
| Pistilli, M | 1 |
| Maguire, MG | 1 |
| Dunaief, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Alpha-Lipoic Acid on the Clinical Outcome of Patients With Sepsis[NCT05808946] | Phase 2/Phase 3 | 60 participants (Anticipated) | Interventional | 2023-03-10 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for thioctic acid and Geographic Atrophy
| Article | Year |
|---|---|
Orally Administered Alpha Lipoic Acid as a Treatment for Geographic Atrophy: A Randomized Clinical Trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Dose-Response Relationship, Drug; Doubl | 2020 |